These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24963517)

  • 21. Advances in immunotherapy for the treatment of glioblastoma.
    Tivnan A; Heilinger T; Lavelle EC; Prehn JH
    J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New weapons against brain tumors. Emerging techniques from multi-national research curb the growth of brain tumors.
    Duke Med Health News; 2007 Oct; 13(10):5. PubMed ID: 18277427
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel approaches and mechanisms of immunotherapy for glioblastoma.
    Hegde M; Bielamowicz KJ; Ahmed N
    Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of immunotherapy and gene therapy for high-grade gliomas.
    Marsh JC; Goldfarb J; Shafman TD; Diaz AZ
    Cancer Control; 2013 Jan; 20(1):43-8. PubMed ID: 23302906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary RNA Therapeutics for Glioblastoma.
    Melnick K; Dastmalchi F; Mitchell D; Rahman M; Sayour EJ
    Neuromolecular Med; 2022 Mar; 24(1):8-12. PubMed ID: 34101090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunotherapy for brain tumor: don't get "Lost in Translation"].
    Okada H
    No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccination in the immunotherapy of glioblastoma.
    Kong Z; Wang Y; Ma W
    Hum Vaccin Immunother; 2018 Feb; 14(2):255-268. PubMed ID: 29087782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
    Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First results on the DCVax phase III trial: raising more questions than providing answers.
    Wick W; van den Bent MJ
    Neuro Oncol; 2018 Sep; 20(10):1283-1284. PubMed ID: 30137551
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
    Van Gool S; De Vleeschouwer S
    Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
    [No Abstract]   [Full Text] [Related]  

  • 32. Celldex hopeful about new immunotherapeutic against brain tumors.
    Hum Vaccin Immunother; 2014; 10(12):3428. PubMed ID: 26052586
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic vaccination for glioblastoma].
    Dietrich PY; Dutoit V
    Med Sci (Paris); 2020 Apr; 36(4):319-322. PubMed ID: 32356704
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunomodulation for glioblastoma.
    Reardon DA; Wen PY; Wucherpfennig KW; Sampson JH
    Curr Opin Neurol; 2017 Jun; 30(3):361-369. PubMed ID: 28368867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme.
    Hdeib A; Sloan AE
    CNS Oncol; 2015; 4(2):63-9. PubMed ID: 25768330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cell immunotherapy: the right bullet for the right target.
    Ghebeh H; Bakr MM; Dermime S
    Hematol Oncol Stem Cell Ther; 2008; 1(1):1-2. PubMed ID: 20063521
    [No Abstract]   [Full Text] [Related]  

  • 37. Next-generation vaccines are showing promise against glioblastoma.
    Dillman RO; Bota DA
    Oncotarget; 2024 Aug; 15():543-548. PubMed ID: 39102214
    [No Abstract]   [Full Text] [Related]  

  • 38. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

  • 39. DENDRITIC CELLS IN GLIOBLASTOMA TREATMENT: A MODERN VIEW OF THE PROBLEM AND OWN EXPERIENCE.
    Glavatskyi O; Khranovska N; Skachkova O; Gorbach O; Khmelnytskyi H; Shuba I; Pedachenko Y; Zemskova O; Zemskova O
    Exp Oncol; 2023 Dec; 45(3):282-296. PubMed ID: 38186026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining immunotherapy with radiation for the treatment of glioblastoma.
    Chow KK; Hara W; Lim M; Li G
    J Neurooncol; 2015 Jul; 123(3):459-64. PubMed ID: 25877468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.